Obesity drugs show early promise against the hormonal disorder PMOS, giving a suffering family hope

A small but growing body of research shows that these obesity medications may also work for the disorder known as PMOS — not only by promoting weight loss but also by improving insulin resistance, hormone balance and ovulation.

A small but growing body of research shows that GLP-1 drugs often used to treat obesity may also work for the hormonal disorder known as PMOS

A small but growing body of research shows that GLP-1 drugs often used to treat obesity may also work for the hormonal disorder known as PMOS

The Adyen logo is seen at the reception desk of the company's headquarters in Amsterdam, Netherlands August 24, 2018. REUTERS/Eva Plevier 13 Aug 2026 01:42PM Aug 13 : Adyen, the Dutch firm that handles payments for Spotify and Microsoft, raised its annual revenue growth forecast on Thursday as it continued to win more

Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity Treatment  wsj.com